Dr. Stella Talic is Head of the Pharmacoepidemiology Research Group and Senior Lecturer in Clinical Epidemiology at the School of Public Health and Preventive Medicine, Monash University. Her research sits at the cutting edge of chronic disease therapeutic prevention and management, with a strong focus on optimising medication use, improving safety and adherence, and ultimately enhancing patient outcomes.

A recognised leader in her field, Dr. Talic serves her advisory role on the Editorial Board of Drugs & Aging journal. Her research has been featured in some of the world’s most prestigious journals, including The BMJ and Nature, underscoring the global relevance and scientific rigour of her work.

In parallel with her research, Dr. Talic is a dedicated educator within the Medical Education, Quality and Research Unit. She brings extensive pedagogical expertise to undergraduate and postgraduate teaching across Medicine and Biomedicine, covering topics such as clinical epidemiology, biostatistics, chronic disease prevention, clinical trials, and clinical pharmacology. She currently serves as Director of the Health Science Honours Course, Chief Examiner for the Clinical Trials postgraduate unit, and Academic Lead for the Master’s Advanced Health Research Practice program.

Dr. Talic also holds honorary appointments at the Baker Heart and Diabetes Institute, The Alfred Hospital, Cabrini Health, and the Centre for Learning Analytics at Monash University, reflecting her broad influence across both clinical and academic domains.

She leads a dynamic, multidisciplinary research team skilled in conducting complex epidemiological investigations, including real-world evidence studies, systematic reviews, mixed-methods research, and pharmacoepidemiological analyses using diverse real-world data sources.

Her contributions have been recognised through several prestigious awards, including the John McNeil Early Career Researcher Award for Best Publication in Public Health and the School’s Best Research Paper Excellence Award in 2021.

Dr. Talic is also a committed mentor, currently supervising a vibrant cohort of Honours, Master’s, and PhD students, many of whom have secured competitive scholarships and published in high-impact journals.

Driven by a passion for research capacity-building and collaborative innovation, Dr. Talic fosters strong international and cross-sector partnerships. Her work continues to shape evidence-based, consumer-informed solutions to some of the most pressing challenges in pharmacoepidemiology and public health today.

Medicine (Undergraduate and Postgraduate)

• Evidence Based Clinical Practice EBCP 3B (Lecturer)
• Evidence Based Medicine EBM 4C (Lecturer)

Public Health (Undergraduate)

• Treatments and Technologies - PBH2006 (Coordinator and Chief Examiner)
• Foundations of Epidemiology - PBH2001 (Lecturer)
• Chronic Disease Epidemiology - PBH3009 (Coordinator and Chief Examiner)

Public Health (Postgraduate)

• Research in advanced health professional practice MAP 5000 (Course Coordinator)
• Clinical Trials MPH5236 (Chief Examiner and Unit Coordinator)

Pharmacy (Postgraduate)

• Evidence Based Clinical Practice PGCP5101 (Lecturer)

Biomedicine (Undergraduate)

• Biomedical basis and Epidemiology of Human Disease BMS3052 (Lecturer)

• Pharmacoepidemiology
• Epidemiology of chronic diseases and prevention 
• Therapeutic prevention, treatment and outcome improvement 
• Pharmacoeconomics
• Quality improvement
• Patient safety
• Global health 
• Translational Medicine